1. Current Status, Position
Prof. Dr. Steven Simoens is currently Professor of Health Economics at KU Leuven.
Steven Simoens is a Commercial Engineer (KU Leuven, 1997), who later specialised in health economics and obtained a MSc in Health Economics (University of York, 1998) and a PhD in Economics (University of Aberdeen, 2001).
3. Research Area
The research interests of Steven Simoens focus on health economic aspects of medicinal products. Steven Simoens has carried out numerous cost(-of-illness) analyses, economic evaluations and budget impact analyses of medicinal products. He has also worked extensively in the area of policy relating to market access of medicinal products, with a particular interest in oncology medicinal products, orphan medicinal products, generic and biosimilar medicinal products, and shortages of medicinal products.
4. Conflict of interest: Steven Simoens is one of the founders of the KU Leuven Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL). He has conducted biosimilar research sponsored by Hospira (now Pfizer) and by Pfizer. He is involved in a stakeholder roundtable on biosimilars sponsored by Amgen, Pfizer and MSD, and has participated in an advisory board meeting on biosimilars for Pfizer.